396 related articles for article (PubMed ID: 16555324)
21. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation.
Belli LS; Zavaglia C; Alberti AB; Poli F; Rondinara G; Silini E; Taioli E; de Carlis L; Scalamogna M; Forti D; Pinzello G; Idèo G
Hepatology; 2000 Jun; 31(6):1345-50. PubMed ID: 10827162
[TBL] [Abstract][Full Text] [Related]
22. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.
Jarcho J; Naftel DC; Shroyer TW; Kirklin JK; Bourge RC; Barr ML; Pitts DG; Starling RC
J Heart Lung Transplant; 1994; 13(4):583-95; discussion 595-6. PubMed ID: 7947874
[TBL] [Abstract][Full Text] [Related]
23. A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.
Margarit C; Bilbao I; Castells L; Lopez I; Pou L; Allende E; Escartin A
Transpl Int; 2005 Dec; 18(12):1336-45. PubMed ID: 16297052
[TBL] [Abstract][Full Text] [Related]
24. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
25. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
26. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
[TBL] [Abstract][Full Text] [Related]
27. Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome.
Carmiel-Haggai M; Fiel MI; Gaddipati HC; Abittan C; Hossain S; Roayaie S; Schwartz ME; Gondolesi G; Emre S; Schiano TD
Liver Transpl; 2005 Dec; 11(12):1567-73. PubMed ID: 16315297
[TBL] [Abstract][Full Text] [Related]
28. DR antigens influence graft outcome and HCV recurrence after liver transplantation.
Kimball P; Stravitz T
Transplant Proc; 2005 Mar; 37(2):1099-100. PubMed ID: 15848634
[TBL] [Abstract][Full Text] [Related]
29. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
[TBL] [Abstract][Full Text] [Related]
30. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P
Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436
[TBL] [Abstract][Full Text] [Related]
31. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
[TBL] [Abstract][Full Text] [Related]
32. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.
Sanchez EQ; Levy MF; Goldstein RM; Fasola CG; Tillery GW; Netto GJ; Watkins DL; Weinstein JS; Murray NG; Byers D; Christensen LL; Klintmalm GB
Transplantation; 2003 Dec; 76(11):1583-8. PubMed ID: 14702528
[TBL] [Abstract][Full Text] [Related]
33. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
[TBL] [Abstract][Full Text] [Related]
34. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
35. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
36. HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.
Belli LS; Burra P; Poli F; Battista Alberti A; Silini E; Zavaglia C; Fagiuoli S; Prando D; Espadas de Arias A; Boninsegna S; Tinelli C; Scalamogna M; de Carlis L; Pinzello G
Gastroenterology; 2006 Mar; 130(3):695-702. PubMed ID: 16530511
[TBL] [Abstract][Full Text] [Related]
37. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
[TBL] [Abstract][Full Text] [Related]
38. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
Lawal A; Ghobrial R; Te H; Artinian L; Eastwood D; Schiano TD
Transplant Proc; 2007 Dec; 39(10):3261-5. PubMed ID: 18089367
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
[TBL] [Abstract][Full Text] [Related]
40. The influence of HLA mismatches and immunosuppression on kidney graft survival: an analysis of more than 1300 patients.
Martins L; Fonseca I; Sousa S; Matos C; Santos J; Dias L; Henriques AC; Sarmento AM; Cabrita A
Transplant Proc; 2007 Oct; 39(8):2489-93. PubMed ID: 17954156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]